Direkt zum Inhalt
Merck

Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4.

Journal of lipid research (2006-02-16)
Christian R H Raetz, Teresa A Garrett, C Michael Reynolds, Walter A Shaw, Jeff D Moore, Dale C Smith, Anthony A Ribeiro, Robert C Murphy, Richard J Ulevitch, Colleen Fearns, Donna Reichart, Christopher K Glass, Chris Benner, Shankar Subramaniam, Richard Harkewicz, Rebecca C Bowers-Gentry, Matthew W Buczynski, Jennifer A Cooper, Raymond A Deems, Edward A Dennis
ZUSAMMENFASSUNG

The LIPID MAPS Consortium (www.lipidmaps.org) is developing comprehensive procedures for identifying all lipids of the macrophage, following activation by endotoxin. The goal is to quantify temporal and spatial changes in lipids that occur with cellular metabolism and to develop bioinformatic approaches that establish dynamic lipid networks. To achieve these aims, an endotoxin of the highest possible analytical specification is crucial. We now report a large-scale preparation of 3-deoxy-D-manno-octulosonic acid (Kdo)(2)-Lipid A, a nearly homogeneous Re lipopolysaccharide (LPS) sub-structure with endotoxin activity equal to LPS. Kdo(2)-Lipid A was extracted from 2 kg cell paste of a heptose-deficient Escherichia coli mutant. It was purified by chromatography on silica, DEAE-cellulose, and C18 reverse-phase resin. Structure and purity were evaluated by electrospray ionization/mass spectrometry, liquid chromatography/mass spectrometry and (1)H-NMR. Its bioactivity was compared with LPS in RAW 264.7 cells and bone marrow macrophages from wild-type and toll-like receptor 4 (TLR-4)-deficient mice. Cytokine and eicosanoid production, in conjunction with gene expression profiling, were employed as readouts. Kdo(2)-Lipid A is comparable to LPS by these criteria. Its activity is reduced by >10(3) in cells from TLR-4-deficient mice. The purity of Kdo(2)-Lipid A should facilitate structural analysis of complexes with receptors like TLR-4/MD2.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Lipopolysaccharide aus Escherichia coli O111:B4, purified by trichloroacetic acid extraction
Sigma-Aldrich
Kdo2-Lipid A (KLA), ≥90% (HPLC)
Avanti
Kdo2-Lipid A (KLA), Avanti Research - A Croda Brand